Leanna Levine's Biography

Leanna Levine, Founder & CEO, ALine, Inc.

Dr. Levine, founder of ALine, Inc., is an entrepreneur, technologist, and inventor. She has a unique blend of technical expertise in both bioanalytical science and manufacturing process development. Prior to founding ALine, Dr. Levine developed bioanalytical technology to support life science research. While at Monsanto, her lab led the industry in the application of fluorescence polarization for high throughput screening for novel therapeutics. In 1998 she joined Spectrum Laboratories as Director of Hollow Fiber Manufacture and Product Development. Dr. Levine earned her Ph.D. at Washington University, St. Louis, MO , and her B.S. in Biochemistry and BA in German from the University of Missouri, Columbia, MO. In 2003 she was a visiting scholar at the UCLA Anderson School of Business. In 2000 she was the chair of the Gordon Conference on Bioanalytical Sensors. She is the co-author on a dozen publications, and several patents.

Welcome and Introduction by Conference Co-Chair -- Lab-on-a-Chip and Microfluidics -- Inputs and Outputs in Product Engineering

Monday, 13 December 2021 at 14:00

Add to Calendar ▼2021-12-14 10:00:002021-12-14 11:00:00Europe/LondonInputs and Outputs in Product EngineeringLab-on-a-Chip and Microfluidics 2021 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

A unique aspect to point-of-care product development is to determine if the biological or chemical test will perform in a microfluidic system often before the rest of the product concept is thoroughly fleshed out. This means the programmatic priorities are focused on translational research before developing design inputs for a regulated product with an instrument. ALine’s new partnership with Nectar Product Development will enable us to support not just the assay implementation, but also create the entire product development roadmap, including the path to regulatory approval.

Inputs and Outputs in Product Engineering

Tuesday, 14 December 2021 at 10:00

Point-of-care product development can be thought of like the layers of an onion. On the outside is the industrial design for the product and all the human factors considerations that make a product successful in the marketplace. Just below the surface is the electromechanical controls and the software that manage the cartridge function, including controls and calibrations. Another layer down is the cartridge itself, and its interface to the instrument to provide all the needed electromechanical supplies, be it light, heat, pneumatics, or other mechanical subsystems. Then at the heart of this product is the assay itself which is engineered into the cartridge and drives the overall cartridge requirements.

A unique aspect to point of care product development is to determine how the biological or chemical test will perform in a microfluidic system often before the rest of the product concept is thoroughly fleshed out. This means the programmatic priorities are focused on translational research before developing design inputs for a regulated product with an instrument. ALine’s new partnership with Nectar Product Development will enable us to support not just the assay implementation in a microfluidic cartridge, but also create the entire product development roadmap, including the path to regulatory approval.

Add to Calendar ▼2021-12-13 00:00:002021-12-15 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics 2021Lab-on-a-Chip and Microfluidics 2021 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors